These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6132972)

  • 1. HI6 as an antidote to soman poisoning in rhesus monkey respiratory muscles in-vitro.
    Smith AP; Wolthuis OL
    J Pharm Pharmacol; 1983 Mar; 35(3):157-60. PubMed ID: 6132972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of oxime-induced neuromuscular recovery in guinea pig, rat and man following soman poisoning in vitro.
    Smith AP; Van der Wiel HJ; Wolthuis OL
    Eur J Pharmacol; 1981 Mar; 70(3):371-9. PubMed ID: 6262099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic potential of memantine against soman poisoning in rats.
    Stojiljković MP; Škrbić R; Jokanović M; Bokonjić D; Kilibarda V; Vulović M
    Toxicology; 2019 Mar; 416():62-74. PubMed ID: 30682440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicology and pharmacology of bispyridium oximes--insight into the mechanism of action vs Soman poisoning in vivo.
    Clement JG
    Fundam Appl Toxicol; 1981; 1(2):193-202. PubMed ID: 6897946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of mono- and bis-pyridinium oximes versus soman, sarin and tabun poisoning in mice.
    Clement JG
    Fundam Appl Toxicol; 1983; 3(6):533-5. PubMed ID: 6662294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of some bis-pyridinium oximes as antidotes to soman in isolated muscles of several species including man.
    Wolthuis O; Vanwersch RA; Van der Wiel HJ
    Eur J Pharmacol; 1981 Mar; 70(3):355-69. PubMed ID: 6262098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oximes HI-6 and MMB-4 fail to reactivate soman-inhibited human and guinea pig AChE: A kinetic in vitro study.
    Worek F; Thiermann H; Wille T
    Toxicol Lett; 2018 Sep; 293():216-221. PubMed ID: 28993240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New simulators in the prophylaxis against soman poisoning: structural specificity for the depot site(s).
    Van Helden HP; Benschop HP; Wolthuis OL
    J Pharm Pharmacol; 1984 May; 36(5):305-8. PubMed ID: 6145765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of HLö-7 and pyrimidoxime as antidotes of nerve agent poisoning in mice.
    Clement JG; Hansen AS; Boulet CA
    Arch Toxicol; 1992; 66(3):216-9. PubMed ID: 1497487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro pharmacological characterization of the bispyridinium non-oxime compound MB327 and its 2- and 3-regioisomers.
    Niessen KV; Seeger T; Rappenglück S; Wein T; Höfner G; Wanner KT; Thiermann H; Worek F
    Toxicol Lett; 2018 Sep; 293():190-197. PubMed ID: 29024789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of soman-blocked neuromuscular transmission in human and rat muscle by the bispyridinium non-oxime MB327 in vitro.
    Seeger T; Eichhorn M; Lindner M; Niessen KV; Tattersall JE; Timperley CM; Bird M; Green AC; Thiermann H; Worek F
    Toxicology; 2012 Apr; 294(2-3):80-4. PubMed ID: 22349640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HI-6 therapy of soman and tabun poisoning in primates and rodents.
    Hamilton MG; Lundy PM
    Arch Toxicol; 1989; 63(2):144-9. PubMed ID: 2730339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of nerve agent inhibited muscle force production in human intercostal muscle strips with HI 6.
    Seeger T; Niessen KV; Langer P; Gerhardus J; Worek F; Friess H; Bumm R; Mihaljevic AL; Thiermann H
    Toxicol Lett; 2011 Sep; 206(1):72-6. PubMed ID: 21803135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of soman inhibited acetylcholinesterase in vitro and protection against soman in vivo by bispyridinium-2-aldoximes.
    Schoene K; Steinhanses J; Oldiges H
    Biochem Pharmacol; 1983 May; 32(10):1649-51. PubMed ID: 6860352
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for an intramuscular depot of the cholinesterase inhibitor soman in the rat.
    Van Helden HP; Wolthuis OL
    Eur J Pharmacol; 1983 May; 89(3-4):271-4. PubMed ID: 6307710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of bis-pyridinium oximes on neuromuscular blockade induced by highly toxic organophosphates in rat.
    Jovanović D
    Arch Int Pharmacodyn Ther; 1983 Apr; 262(2):231-41. PubMed ID: 6307195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HI-6, an oxime which is an effective antidote of soman poisoning: a structure-activity study.
    Clement JG; Lockwood PA
    Toxicol Appl Pharmacol; 1982 Jun; 64(1):140-6. PubMed ID: 7112578
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the toxicity, pathology, and treatment of cyclohexylmethylphosphonofluoridate (CMPF) poisoning in rhesus monkeys.
    Koplovitz I; Gresham VC; Dochterman LW; Kaminskis A; Stewart JR
    Arch Toxicol; 1992; 66(9):622-8. PubMed ID: 1482284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro.
    Tattersall JE
    Br J Pharmacol; 1993 Apr; 108(4):1006-15. PubMed ID: 7683561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinesterase and carboxylesterase activities in soman poisoned rats treated with bispyridinium mono-oximes HI-6 and HS-6.
    Sterri SH; Lyngaas S; Fonnum F
    Biochem Pharmacol; 1983 May; 32(10):1646-9. PubMed ID: 6860351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.